Back
CBRE Global Real Estate Income Fund Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Sell
39
IGR
CBRE Global Real Estate Income Fund
Last Price:
$4.37
Seasonality Move:
-0.18%
Sell
40
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.52
Seasonality Move:
-3.24%
Sell
39
CBRE Global Real Estate Income Fund (IGR)
is a Sell
Is CBRE Global Real Estate Income Fund a Buy, Sell or Hold?
-
The current CBRE Global Real Estate Income Fund [IGR] share price is $4.35. The Score for IGR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
IGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.07. The Score for AMPH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGR Stock Price Chart
What is CBRE Global Real Estate Income Fund's stock price today?
-
The CBRE Global Real Estate Income Fund share price today is $4.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGR is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $26.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing slight buying pressure.
IGR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 36.46 | Sell |
| Chaikin Money Flow: | 1144080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.33 - 4.71) | Sell |
| Bollinger Bands (100): | (4.63 - 5.11) | Sell |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 49.58 | Sell |
| Chaikin Money Flow: | 55695 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.62 - 27.22) | Sell |
| Bollinger Bands (100): | (23.9 - 28.88) | Sell |
IGR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.28 | Buy |
| 20-day SMA: | 4.46 | Sell |
| 50-day SMA: | 4.73 | Sell |
| 200-day SMA: | 4.97 | Sell |
| 8-day EMA: | 4.32 | Buy |
| 20-day EMA: | 4.45 | Sell |
| 50-day EMA: | 4.56 | Sell |
| 200-day EMA: | 3.03 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.82 | Buy |
| 20-day SMA: | 26.42 | Sell |
| 50-day SMA: | 25.49 | Buy |
| 200-day SMA: | 25.64 | Buy |
| 8-day EMA: | 26.01 | Buy |
| 20-day EMA: | 26.15 | Sell |
| 50-day EMA: | 26.06 | Buy |
| 200-day EMA: | 27.92 | Sell |
CBRE Global Real Estate Income Fund Earnings Growth & IGR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.
CBRE Global Real Estate Income Fund Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||